Discovery and optimization of pyrazoline compounds as B-Raf inhibitors
Matthew O. Duffey(Takeda (United States)), Qin Zhang(Capital Institute of Pediatrics), Ryan Chau(Takeda (United States)), Masayuki Nagayoshi(Millennium Engineering and Integration (United States)), Katherine Galvin(Takeda (United States)), Tricia J. Vos(Millennium Engineering and Integration (United States)), Paul D. Greenspan(Takeda (United States)), Misook Kim(Takeda (United States)), Saurabh Menon(Takeda (United States)), Susan Chen(Millennium Engineering and Integration (United States)), Jane X. Liu(Millennium Engineering and Integration (United States)), Alexandra E. Gould(Takeda (United States)), Shih-Chung Huang(Millennium Engineering and Integration (United States)), Ruth Adams(Millennium Engineering and Integration (United States)), R. Scott Rowland(Millennium Engineering and Integration (United States)), Tianlin Xu(Takeda (United States)), Steven Langston(Takeda (United States)), Li‐Ting Ma(Takeda (United States)), Sean Harrison(Takeda (United States)), Khristofer Garcia(Millennium Engineering and Integration (United States)), Shaoxia Yu(Millennium Engineering and Integration (United States)), Johnny Yang(Millennium Engineering and Integration (United States)), B. K. KULKARNI(Millennium Engineering and Integration (United States)), Christopher Blackburn(Millennium Engineering and Integration (United States))
Cited by 15
Related Papers
Substrate-Assisted Inhibition of Ubiquitin-like Protein-Activating Enzymes: The NEDD8 E1 Inhibitor MLN4924 Forms a NEDD8-AMP Mimetic In Situ
|Molecular Cell|2010|461
A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment
|Nature Medicine|2018|453
Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitor
|Nature Chemical Biology|2017|228